These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6335739)

  • 41. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
    Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphologic changes in epidermis of PUVA-treated patients with psoriasis with or without a history of arsenic therapy.
    Niemi KM; Niemi A; Kanerva L
    Arch Dermatol; 1983 Nov; 119(11):904-9. PubMed ID: 6639110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative immunologic studies in PUVA and SUP (selected ultraviolet phototherapy) treatments].
    Simon N; Hunyadi J
    Z Hautkr; 1982 Sep; 57(17):1268-73. PubMed ID: 7148058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of the fraction of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psoralen/ultraviolet-A radiation (PUVA).
    Moscicki RA; Morison WL; Parrish JA; Bloch KJ; Colvin RB
    J Invest Dermatol; 1982 Sep; 79(3):205-8. PubMed ID: 6809841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigenic stimulation during ultraviolet therapy in man does not result in immunological tolerance.
    Friedmann PS; White SI; Parker S; Moss C; Matthews JN
    Clin Exp Immunol; 1989 Apr; 76(1):68-72. PubMed ID: 2736800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis.
    Morison WL; Wimberly J; Parrish JA; Bloch KJ
    Br J Dermatol; 1983 Apr; 108(4):445-50. PubMed ID: 6838768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of photochemotherapy (PUVA) on cell mediated immunity in the guinea pig.
    Briffa DV; Parker D; Tosca N; Turk JL; Greaves MW
    J Invest Dermatol; 1981 Oct; 77(4):377-80. PubMed ID: 7276622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired contact hypersensitivity in untreated psoriasis and the effects of photochemotherapy and dithranol/UV-B.
    Moss C; Friedmann PS; Shuster S
    Br J Dermatol; 1981 Nov; 105(5):503-8. PubMed ID: 7295567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Puva photohyposensitization in polymorphous light eruptions: evaluation of systemic immunological factors.
    Karvonen J; Viander M; Ilonen J; Jansén CT
    Acta Derm Venereol; 1982; 62(6):497-500. PubMed ID: 6187154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ultraviolet in dermatology: spectra--instruments--possibilities].
    Breit R
    Hautarzt; 1985 Sep; 36(9):496-503. PubMed ID: 4066321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alteration of lymphocyte functions by 8-methoxypsoralen and longwave ultraviolet radiation. I. Suppressive effects of PUVA on T-lymphocyte migration in vitro.
    Okamoto H; Takigawa M; Horio T
    J Invest Dermatol; 1985 Mar; 84(3):203-5. PubMed ID: 3871825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
    Pathak MA; Fitzpatrick TB
    J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mechanisms of inhibitory effect of 8-methoxypsoralen and long-wave ultraviolet light on experimental contact sensitization.
    Horio T; Okamoto H
    J Invest Dermatol; 1982 May; 78(5):402-5. PubMed ID: 7069217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photosensitization of Trichophyton with 8-methoxypsoralen to UV-A light radiation.
    Horio T; Watanabe S
    Br J Dermatol; 1981 Apr; 104(4):397-404. PubMed ID: 7236504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective inactivation of lymphocytes after psoralen/ultraviolet light (PUVA) treatment without affecting systemic immune responses.
    Laskin JD; Mermelstein FH; Heindel ND; Ron Y
    J Leukoc Biol; 1993 Aug; 54(2):138-44. PubMed ID: 7689628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Humoral and cellular immunity in patients with psoriasis treated by the PUVA method].
    Placek W; Sztaba-Kania M
    Przegl Dermatol; 1986; 73(1):18-22. PubMed ID: 3487814
    [No Abstract]   [Full Text] [Related]  

  • 59. Psoralens and related compounds in the treatment of psoriasis.
    McEvoy MT; Stern RS
    Pharmacol Ther; 1987; 34(1):75-97. PubMed ID: 3310045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of PUVA therapy on circulating T lymphocytes].
    Mutevelić-Arslanagić N
    Med Arh; 1992; 46(1-2):23-4. PubMed ID: 1345548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.